The post hoc analysis of pooled data from the Semaglutide Treatment Effect in People with Obesity (STEP) 1, 2, 3, and 5 trials indicated that semaglutide treatment at 2.4 mg did not increase the risk of depressive symptoms or suicidal ideation compared to placebo, while demonstrating a statistically significant yet clinically negligible decrease in depressive symptoms [75]
HbA1c is a long-term marker of blood sugar control
Your doctor must submit clinical notes proving these criteria
MG: Supervision, Writing review & editing
In this article, we'll explore how GLP-1-induced constipation occurs, its underlying causes, and effective ways to find relief, allowing you to stay on track with your weight loss or health journey
Next, restore your glow with a Panga Custom Facial , tailored to your skin type and concerns for radiant, refreshed results